View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
July 11, 2011

New Gonorrhoea Strain is “Resistant” to Antibiotics

New drugs to delay the spread of gonorrhoea are urgently needed as a new strain of the STD has become resistant to antibiotics, scientists in Sweden have found. The bacterial infection has, until now, been easily treatable with antibiotics, but researchers from the Swedish Reference Lab

By cms admin

New drugs to delay the spread of gonorrhoea are urgently needed as a new strain of the STD has become resistant to antibiotics, scientists in Sweden have found.

The bacterial infection has, until now, been easily treatable with antibiotics, but researchers from the Swedish Reference Laboratory warned that the new strain, H041, is very effective at mutating.

Scientists have warned that the strain, first found in Japan, could become a global threat to public health.

Researchers at the Swedish lab identified the genetic mutations responsible for the new strain’s extreme resistance to all cephalosporin-class antibiotics.

Dr Magnus Unemo, from the Swedish Research Laboratory for Pathogenic Neisseria said, “Since antibiotics became the standard treatment for gonorrhoea in the 1940s, this bacterium has shown a remarkable capacity to develop resistance mechanisms to all drugs introduced to control it.

“While it is still too early to assess if this new strain has become widespread, the history of newly emergent resistance in the bacterium suggests that it may spread rapidly unless new drugs and effective treatment programmes are developed.”

The team of researchers will present its findings at a conference run by the International Society for Sexually Transmitted Disease Research in Canada.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology